A detailed history of Deseret Mutual Benefit Administrators transactions in Amgen Inc stock. As of the latest transaction made, Deseret Mutual Benefit Administrators holds 5,613 shares of AMGN stock, worth $1.79 Million. This represents 0.82% of its overall portfolio holdings.

Number of Shares
5,613
Previous 5,576 0.66%
Holding current value
$1.79 Million
Previous $1.59 Million 10.6%
% of portfolio
0.82%
Previous 0.8%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

BUY
$262.75 - $319.31 $9,721 - $11,814
37 Added 0.66%
5,613 $1.75 Million
Q1 2024

May 09, 2024

BUY
$268.87 - $324.56 $42,481 - $51,280
158 Added 2.92%
5,576 $1.59 Million
Q4 2023

Feb 13, 2024

SELL
$255.7 - $288.46 $467,675 - $527,593
-1,829 Reduced 25.24%
5,418 $1.56 Million
Q3 2023

Nov 09, 2023

SELL
$218.65 - $271.46 $296,708 - $368,371
-1,357 Reduced 15.77%
7,247 $1.95 Million
Q2 2023

Aug 07, 2023

SELL
$214.27 - $253.37 $1,928 - $2,280
-9 Reduced 0.1%
8,604 $1.91 Million
Q1 2023

May 09, 2023

SELL
$225.79 - $275.2 $30,933 - $37,702
-137 Reduced 1.57%
8,613 $2.08 Million
Q4 2022

Feb 13, 2023

SELL
$229.03 - $291.01 $864,588 - $1.1 Million
-3,775 Reduced 30.14%
8,750 $2.3 Million
Q3 2022

Nov 03, 2022

SELL
$224.46 - $253.15 $231,867 - $261,503
-1,033 Reduced 7.62%
12,525 $2.82 Million
Q2 2022

Aug 05, 2022

BUY
$230.71 - $256.74 $533,170 - $593,326
2,311 Added 20.55%
13,558 $3.3 Million
Q1 2022

May 11, 2022

SELL
$219.27 - $242.57 $222,120 - $245,723
-1,013 Reduced 8.26%
11,247 $2.72 Million
Q4 2021

Feb 09, 2022

BUY
$198.88 - $227.6 $86,711 - $99,233
436 Added 3.69%
12,260 $2.76 Million
Q3 2021

Nov 04, 2021

BUY
$212.27 - $248.7 $1.74 Million - $2.04 Million
8,218 Added 227.9%
11,824 $2.51 Million
Q2 2021

Aug 06, 2021

BUY
$233.58 - $259.14 $842,289 - $934,458
3,606 New
3,606 $879,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Deseret Mutual Benefit Administrators Portfolio

Follow Deseret Mutual Benefit Administrators and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deseret Mutual Benefit Administrators, based on Form 13F filings with the SEC.

News

Stay updated on Deseret Mutual Benefit Administrators with notifications on news.